Bupivacaine HCl in 0.9% Sodium Chloride in all doses, all strengths, and packaging.

FDA Recall #D-0429-2018 — Class II — December 27, 2017

Recall #D-0429-2018 Date: December 27, 2017 Classification: Class II Status: Terminated

Product Description

Bupivacaine HCl in 0.9% Sodium Chloride in all doses, all strengths, and packaging.

Reason for Recall

Lack of sterility assurance.

Recalling Firm

Pharmedium Services, LLC — Lake Forest, IL

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

297 bags

Distribution

U.S.A. Nationwide

Code Information

All lots remaining within expiry.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated